TMEM164 is a new determinant of autophagy-dependent ferroptosis

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Macroautophagy (autophagy) is a cellular degradation process crucial for survival during nutrient deprivation.
• Dysregulated autophagy can lead to programmed cell death, including iron-dependent ferroptosis.
• Understanding the specific mechanisms of ferroptosis is vital for developing novel cancer therapies.

Purpose of the Study:

• To investigate the role of transmembrane protein 164 (TMEM164) in regulating autophagosome formation during ferroptosis.
• To elucidate the molecular mechanisms by which TMEM164 influences ferroptotic cell death.
• To assess the therapeutic potential of targeting TMEM164 in anticancer strategies.

Main Methods:

• Utilized cell culture models to study autophagy and ferroptosis.
• Employed genetic manipulation techniques to assess the function of TMEM164 and ATG5.
• Analyzed protein and lipid degradation pathways involved in ferroptosis.
• Evaluated the in vivo efficacy of ferroptosis-mediated cytotoxicity in mouse models.
• Correlated TMEM164 expression with patient survival and immune cell infiltration in pancreatic cancer.

Main Results:

• TMEM164 selectively mediates ATG5-dependent autophagosome formation during ferroptosis, distinct from starvation-induced autophagy.
• TMEM164-driven autophagy degrades key proteins like ferritin and GPX4, increasing iron levels and lipid peroxidation.
• Loss of TMEM164 impairs ferroptosis and reduces its anticancer efficacy in vivo.
• High TMEM164 expression in pancreatic cancer patients correlates with better survival and increased immune cell infiltration.

Conclusions:

• TMEM164 plays a critical role in a novel mode of autophagy-dependent ferroptosis.
• TMEM164 promotes ferroptosis by degrading ferritin and GPX4, leading to iron accumulation and cell death.
• TMEM164 represents a potential therapeutic target for enhancing ferroptosis-based cancer treatments.